- $880.81m
- $853.44m
- $82.03m
U.S. STOCKS ON THE MOVE-Cellectar Biosciences, CASI Pharmaceuticals, Pfizer
U.S. STOCKS ON THE MOVE-Cellectar Biosciences, Paysign, Supernus
PaySign: Canaccord Genuity downgrades on lower visibility of core businesses
U.S. RESEARCH ROUNDUP-Apartment Income REIT, Paysign, Wesco International
Paysign drops on Q3 loss
U.S. RESEARCH ROUNDUP- Arista Networks, Casper Sleep, G1 Therapeutics
Brief: Paysign Files For Non-Timely 10-Q With U.S. SEC
Brief: Paysign Reports Q3 Loss Per Share Of $0.12
Brief: Paysign Inc Reports Q2 Revenue Of $8.6 Mln
Brief: Paysign - Files Prelim Prospectus Related To Potential Resale Of Up To 1.5 Mln Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Paysign Reports Q1 Non-GAAP Earnings Per Share Of $0.05
U.S. RESEARCH ROUNDUP-Beyond Meat, McDonald's, Sunnova Energy International
Brief: Paysign Receives Notification Of Deficiency From Nasdaq Related To Delayed Filing Of Annual Report On Form 10-K
Paysign Inc: Drops after Q4 earnings delayed for third time
Brief: Paysign, Inc. To Postpone Yearend Earnings Call
Brief: Paysign, Inc. To Delay Yearend Earnings Call Until March 31, 2020
Brief: Paysign Announces Preliminary Full-Year 2019 Financial Highlights And Delay Of Form 10-K Filing
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:00 AM
Paysign jumps on upbeat Q3 profit